Incyte (INCY)
(Delayed Data from NSDQ)
$51.68 USD
+0.50 (0.98%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $51.76 +0.08 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for Incyte Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,696 | 3,395 | 2,986 | 2,667 | 2,159 |
Cost Of Goods | 255 | 207 | 151 | 131 | 114 |
Gross Profit | 3,441 | 3,188 | 2,835 | 2,535 | 2,045 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,820 | 2,608 | 2,250 | 2,799 | 1,643 |
Income After Depreciation & Amortization | 621 | 579 | 586 | -264 | 402 |
Non-Operating Income | 216 | -48 | -13 | 34 | 87 |
Interest Expense | 3 | 3 | 2 | 2 | 2 |
Pretax Income | 834 | 529 | 570 | -232 | 487 |
Income Taxes | 237 | 188 | -378 | 63 | 40 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 598 | 341 | 949 | -296 | 447 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 598 | 341 | 949 | -296 | 447 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 703 | 647 | 644 | -212 | 457 |
Depreciation & Amortization (Cash Flow) | 83 | 68 | 58 | 52 | 55 |
Income After Depreciation & Amortization | 621 | 579 | 586 | -264 | 402 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 225.93 | 223.96 | 222.07 | 218.07 | 217.66 |
Diluted EPS Before Non-Recurring Items | 2.69 | 2.11 | 2.11 | -1.06 | 2.23 |
Diluted Net EPS (GAAP) | 2.65 | 1.52 | 4.27 | -1.36 | 2.05 |
Fiscal Year end for Incyte Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,013.34 | 919.03 | 954.61 | 808.67 |
Cost Of Goods | NA | 69.75 | 60.09 | 68.33 | 56.82 |
Gross Profit | NA | 943.59 | 858.93 | 886.28 | 751.85 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 756.32 | 644.23 | 692.50 | 727.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 187.27 | 214.70 | 193.78 | 24.77 |
Non-Operating Income | NA | 84.49 | 19.72 | 84.48 | 27.56 |
Interest Expense | NA | 0.80 | 0.62 | 0.66 | 0.47 |
Pretax Income | NA | 270.96 | 233.80 | 277.60 | 51.86 |
Income Taxes | NA | 69.88 | 62.53 | 74.06 | 30.15 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 201.08 | 171.27 | 203.55 | 21.70 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 201.08 | 171.27 | 203.55 | 21.70 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 226.13 | 226.17 | 225.65 | 225.59 |
Diluted EPS Before Non-Recurring Items | NA | 0.82 | 0.91 | 0.77 | 0.18 |
Diluted Net EPS (GAAP) | NA | 0.89 | 0.76 | 0.90 | 0.10 |